+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Smoking Cessation And Nicotine Deaddiction - Pipeline Insight, 2025 - Product Thumbnail Image

Smoking Cessation And Nicotine Deaddiction - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Diabetic Hypoglycemia - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Hypoglycemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Drug-Resistant Refractory Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Drug-Resistant Refractory Epilepsy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dupuytren Contracture - Pipeline Insight, 2025 - Product Thumbnail Image

Dupuytren Contracture - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2025 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Familial Primary Pulmonary Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Primary Pulmonary Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Fuchs Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Fuchs Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Covid-19 - Pipeline Insight, 2025 - Product Thumbnail Image

Covid-19 - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 450 Pages
  • Global
From
Gigantism - Pipeline Insight, 2025 - Product Thumbnail Image

Gigantism - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Onchocerciasis - Pipeline Insight, 2025 - Product Thumbnail Image

Onchocerciasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Burns - Pipeline Insight, 2025 - Product Thumbnail Image

Burns - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Wrinkles - Pipeline Insight, 2025 - Product Thumbnail Image

Wrinkles - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Becker Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Becker Muscular Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Heavy Metal Poisoning - Pipeline Insight, 2025 - Product Thumbnail Image

Heavy Metal Poisoning - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Herpes Keratitis - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Keratitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hospital Acquired Candida Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Hospital Acquired Candida Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more